New Drug Slows Glioblastoma Cells in Lab Tests
Original title: An ALKBH3 Inhibitor HUHS199 Suppresses Proliferation of Glioblastoma Cells by Targeting 1-Methyladenosine on GADD45A mRNA.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done on tumor cells in a lab, not in people.
The short version
Scientists built a new drug that slowed brain tumor cells growing in a dish.
What was studied. Researchers looked at a protein called ALKBH3 in glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary, a fast growing brain tumor. They tested a new drug, HUHS199, made to block that protein in tumor cells.
What they found. ALKBH3 was present at high levels in glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary tissue taken from patients. When the team turned ALKBH3 down, the tumor cells grew less. The drug HUHS199 also slowed tumor cell growth, and higher doses slowed it more.
What this means, and what it doesn't
What it could mean: This gives scientists a new target to aim at in glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary. It is a starting point for more lab work, not a treatment plan.
What it doesn't mean: This does not mean a new treatment is close. The work was done on cells in the lab, not in people. The drug has not been tested in any patient. It is not a cure, and no doctor can offer it today.
Source: PubMed, September 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.